Investor Relations
MAP Pharmaceuticals is an innovative drug company focused on providing better treatments for patients with neurological diseases. Taking an integrated scientific approach, MAP Pharmaceuticals seeks to place better care into patients' hands by enhancing how proven drugs perform, through targeted dosing regimens and novel delivery systems. MAP Pharmaceuticals' goal is to develop treatments that provide patients with greater control, improved efficacy and fewer side effects.
Recent Releases
Jan 22, 2013
Allergan, Inc. to Acquire MAP Pharmaceuticals, Inc.
Jan 2, 2013
MAP Pharmaceuticals to Present at the 31st Annual J.P. Morgan Healthcare Conference
